/
PHG
$27.19-$0.02 (-0.07%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$26.3B
972M shares
52-week range
$22.90 – $32.24
46% from low
Exchange
NYSE
CS
Borrow rate
1.95%
Moderate
Price (6 mo)
Loading chart…
Change$-13.32
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.12B | $17.15B | $17.31B | $17.16B | $17.83B | $18.17B | $18.02B | $17.83B |
| Cost of revenue | $9.57B | $9.20B | $9.40B | $9.99B | $10.63B | $10.72B | $10.25B | $9.78B |
| Gross profit | $8.55B | $7.95B | $7.91B | $7.17B | $7.19B | $7.45B | $7.77B | $8.06B |
| Gross margin | 47.2% | 46.4% | 45.7% | 41.8% | 40.4% | 41.0% | 43.1% | 45.2% |
| R&D | $1.76B | $1.79B | $1.91B | $1.81B | $2.09B | $1.89B | $1.75B | $1.70B |
| Operating income | $1.72B | $1.37B | $1.26B | $553.0M | −$1.53B | −$115.0M | $529.0M | $1.42B |
| EBITDA | $2.79B | $2.62B | $2.75B | $2.00B | $115.0M | $1.04B | $1.85B | $2.64B |
| Net income | $1.09B | $1.17B | $1.19B | $3.32B | −$1.61B | −$466.0M | −$702.0M | $895.0M |
| Net margin | 6.0% | 6.8% | 6.9% | 19.3% | -9.0% | -2.6% | -3.9% | 5.0% |
| EPS (diluted) | 1.09 | 1.20 | 1.23 | 0.64 | -1.68 | -0.49 | -0.75 | 0.93 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $18.3B | $1.56 | $1.35–$1.83 | 3 |
| 2027 | $19.1B | $1.74 | $1.52–$2.06 | 3 |
| 2028 | $19.9B | $1.93 | $1.86–$2.08 | 1 |
| 2029 | $20.9B | $2.05 | $1.97–$2.20 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$58.28
Price
$27.19
Implied upside
+114%
Peer comparison
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
www.philips.com- Employees
- 64,317
- IPO / List date
- Aug 18, 1976
Held by traders on TradeandTell
No one on the platform currently holds PHG.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PHG as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 7.20% ($1.96/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-13 | $0.9900 | 2026-06-03 |
| 2025-05-13 | $0.9673 | 2025-06-06 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-05-13 | 1.037127656-for-1 |
| 2025-05-13 | 1.0423095962-for-1 |
| 2024-05-09 | 1.03416654-for-1 |
| 2023-05-11 | 1.0446616-for-1 |
| 2022-05-12 | 1.0366053648-for-1 |
Recent trades on TradeandTell
No one on the platform has traded PHG yet.
